PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAJ0. A total of 5 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 4.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $145,000 | -99.0% | 12,500,000 | 0.0% | 0.01% | -99.1% |
Q2 2023 | $14,952,188 | +8306671.1% | 12,500,000 | -16.7% | 0.66% | +9314.3% |
Q1 2023 | $180 | -98.8% | 15,000,000 | 0.0% | 0.01% | -98.4% |
Q4 2022 | $15,525 | -100.0% | 15,000,000 | 0.0% | 0.43% | -98.0% |
Q3 2022 | $1,501,410,000 | +9760.8% | 15,000,000 | 0.0% | 21.08% | +5975.8% |
Q2 2022 | $15,226,000 | -12.5% | 15,000,000 | 0.0% | 0.35% | -14.3% |
Q1 2022 | $17,400,000 | +23.5% | 15,000,000 | 0.0% | 0.40% | +31.5% |
Q4 2021 | $14,086,000 | – | 15,000,000 | – | 0.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 15,000,000 | $1,501,410,000 | 21.08% |
WHITEBOX ADVISORS LLC | 5,000,000 | $4,904,000 | 0.14% |
UBS OCONNOR LLC | 4,000,000 | $4,200,000,000 | 0.08% |
CITIGROUP INC | 2,500,000 | $2,452,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |